NCT02383901View on ClinicalTrials.gov

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

May 31, 2016

Conditions
Osteosarcoma
Interventions
DRUG

Methotrexate

The study includes osteosarcoma patients who have received MAP treatment, MAP treatment contains 12 courses of Methotrexate

Trial Locations (5)

1094

Semmelweis Egyetem II. Sz. Gyermekklinika, Budapest

N-0424

Oslo University Hospital, Oslo

01 211

Intytut Matki Dziecka Klinika Chirurgii Onkologicznej Dzieci i Młodzieży, Warsaw

221 85

Skåne University Hospital, Lund

SE-17176

Karolinska University Hospital, Sweden, Stockholm

Sponsors

Lead Sponsor

Isofol Medical AB
All Listed Sponsors
lead

Isofol Medical AB

INDUSTRY